LINCOLN Pharmaceuticals | LINCOPH | NSE - Pharmaceuticals


Performance Valuation Growth Insiders Summary Balance Sheet Income Statement Cash Flow Quarterly
INR in Million. Fiscal year ends in March. Figures are consolidated and restated..

Upgrade Membership to see 10 year accurate financial statements.
 Chart
2017
2018
2019
2020
2021
Revenue
Revenue
3,6063,6163,6623,8654,242
Cost of revenue
Cost of revenue
-2,171-1,935-1,754-1,829-1,977
Gross Profit
Gross Profit
1,435
1,681
1,908
2,036
2,264
Sales, general & ad...
Sales, general and administrative
-971-1,158-1,236-1,380-1,393
Depreciation
Depreciation and amortization
-55-61-67-73-76
Provision
Provision
00000
Other op inc/exp...
Other operating income/expenses
00000
Operating income
Operating income EBIT
409
462
605
582
796
 
      
Profit before tax
Profit before tax
368462622672837
Net Income
Net income
271
346
487
514
622
 
 
 
 
 
 
 
EPS Basic
EPS Basic in Rupees
15.14
17.31
24.37
25.72
31.10